Conventional ubiquitination regulates key cellular processes by catalysing the ATP-dependent formation of an isopeptide bond between ubiquitin (Ub) and primary amines in substrate proteins 1 . Recently, the SidE family of bacterial effector proteins (SdeA, SdeB, SdeC and SidE) from pathogenic Legionella pneumophila were shown to use NAD + to mediate phosphoribosyl-linked ubiquitination of serine residues in host proteins 2,3 . However, the molecular architecture of the catalytic platform that enables this complex multistep process remains unknown. Here we describe the structure of the catalytic core of SdeA, comprising mono-ADPribosyltransferase (mART) and phosphodiesterase (PDE) domains, and shed light on the activity of two distinct catalytic sites for serine ubiquitination. The mART catalytic site is composed of an α-helical lobe ( To understand the mode of ubiquitination by SdeA, we sought structural insights into the function of this enzyme. First, we identified SdeA residues 213 to 907 (SdeA 213-907 ), comprising both PDE and mART domains, as the minimal stable fragment that can ubiquitinate the known SdeA substrate Rab33b 2,3 , albeit less efficiently than full-length SdeA (SdeA FL ) (Extended Data Fig. 1a, b) . We crystallized SdeA 213-907 and determined its structure at 2.8 Å (Supplementary  Table 1 , Supplementary Information). In the structure, each asymmetric unit contained one molecule of SdeA 213-907 comprising three distinct domains (Fig. 1a) . The PDE domain spans residues 222-593 and is α-helical. Structure comparison analysis revealed that the PDE domain of SdeA is most similar to that of the Legionella effector protein lpg1496 (PDB: 5BU2) (root mean squared deviation (r.m.s.d.) of 2.3 Å over 239 Cα atoms) 4 . The closest structural mammalian homologue
ubiquitination. Using degenerate substrate peptides and newly identified ubiquitination sites in RTN4B, we show that disordered polypeptides with hydrophobic residues surrounding the target serine residues are preferred substrates for SdeA ubiquitination. Infection studies with L. pneumophila expressing substrate-binding mutants of SdeA revealed that substrate ubiquitination, rather than modification of the cellular ubiquitin pool, determines the pathophysiological effect of SdeA during acute bacterial infection.
To understand the mode of ubiquitination by SdeA, we sought structural insights into the function of this enzyme. First, we identified SdeA residues 213 to 907 (SdeA 213-907 ), comprising both PDE and mART domains, as the minimal stable fragment that can ubiquitinate the known SdeA substrate Rab33b 2, 3 , albeit less efficiently than full-length SdeA (SdeA FL ) (Extended Data Fig. 1a, b) . We crystallized SdeA 213-907 and determined its structure at 2.8 Å (Supplementary  Table 1 , Supplementary Information). In the structure, each asymmetric unit contained one molecule of SdeA 213-907 comprising three distinct domains (Fig. 1a) . The PDE domain spans residues 222-593 and is α-helical. Structure comparison analysis revealed that the PDE domain of SdeA is most similar to that of the Legionella effector protein lpg1496 (PDB: 5BU2) (root mean squared deviation (r.m.s.d.) of 2.3 Å over 239 Cα atoms) 4 . The closest structural mammalian homologue biochem2.de 5 . The mART domain is situated at the C terminus (residues 594-907) and comprises two distinct and spatially separated lobes, the α-helical lobe (AHL, residues 594-758) and the mART core (residues 759-907). The mART core interacts strongly with the PDE domain and is composed mostly of β-strands with a couple of α-helices. Unexpectedly, in our crystal structure, the AHL has no physical proximity to the mART core; this contrasts with the structures of other bacterial ADP-ribosylating enzymes, in which the AHL is an integral part of the mART domain and contributes to NAD + binding and ADPribosylation of the substrate 6 . The solution structure of SdeA 213-907 that was determined using small-angle X-ray scattering (SAXS) revealed a similar orientation of AHL in solution as seen in the crystal (Extended Data Fig. 1c, Supplementary Table 2 , Supplementary Information). Superimposition of the AHLs of SdeA and Vis toxin, a bacterial ADPribosyl transferase from Vibrio splendidus (PDB: 4Y1W), revealed a proximal conformation of the AHL that differed substantially from that seen in the crystal structure (Fig. 1b) . We hypothesize that the AHL of SdeA 213-907 could transiently adopt a conformation proximal to the mART core for NAD + binding and processing (Fig. 1b) . Consistent with this hypothesis, deletion of the AHL (residues 599-758) led to a complete loss of ADP-ribosylation of ubiquitin and ε-NAD + hydrolysis 7 ( Fig. 1c, Extended Data Fig. 2a ). Mutation of residues in the two flexible loops flanking the AHL affected substrate ubiquitination in SdeA 213-907 but not in SdeA FL , suggesting that the dynamic conformational shift of AHL occurs only in the context of SdeA 213-907 , while the position of AHL in SdeA FL is fixed in the proximal, active form by the C-terminal region (CTR, residues 909-1499) (Extended Data Fig. 2b, c) . Accordingly, SdeA FL exhibited much greater NAD + sensitivity in our in vitro ubiquitination experiments, resulting in complete modification of 10 µM ubiquitin with 20 µM NAD + , whereas the activity of SdeA 213-907 gradually increased with increasing NAD + concentration (Fig. 1d) . Similarly, SdeA FL exhibited a marked increase in activity compared to SdeA 213-907 with respect to the ε-NAD + hydrolysis kinetics measured in vitro (Fig. 1e) . SdeA 213-907 did not detectably ubiquitinate Rab33b in HEK293T cells, perhaps owing to insufficient cellular NAD + concentration (Extended Data Fig. 2d ). Moreover, limited proteolysis experiments with SdeA constructs containing different C-terminal extensions revealed that the construct ending at residue 1233 is indigestible, whereas shorter constructs collapse to SdeA 213-907, indicating that the CTR induces a compact or closed state of the SdeA structure (Extended Data Fig. 2e ). Mixing purified CTR (residues 909-1499) or shorter CTR (residues 909-1233) with SdeA 213-907 increased the Letter reSeArCH catalytic activity of SdeA 213-907 to the same level as SdeA FL (Fig. 1e) . These results are consistent with the crystal structure of a longer construct of SdeA in which CTR stabilizes the proximal orientation of AHL 8 . Detailed analysis of the structure of the mART domain and its interaction with the PDE domain is presented in the Supplementary Information (Extended Data Figs. 3, 4) .
The PDE domain of SdeA hydrolyses ADP-ribosylated ubiquitin (ADPR-Ub) and catalyses the transfer of ubiquitin to serine residues of the substrate protein via a phosphoribose linker 3 . The catalytic pocket of PDE in SdeA is lined by several conserved histidines (Fig. 2a) and mutation of H277 or H407 has been shown to abolish the activity of the PDE domain 9 . We hypothesized that the PR-ubiquitination reaction by SdeA might take place via a transient intermediate involving covalent attachment of phosphate to a catalytic histidine residue 10 . Phosphohistidine intermediates are difficult to observe owing to their extreme lability 11, 12 . Therefore, we introduced a few key mutations into the catalytic pocket of the PDE domain to stabilize a potential intermediate. Unexpectedly, we observed a SdeA-Ub intermediate that was sensitive to heat treatment only in the H407N mutant (Fig. 2b,  Extended Data Fig. 5a ). Using mass-spectrometry analysis of the tryptic digest of the intermediate reaction, we could identify an ion with the exact mass of ubiquitin (Ub) 34-48 bridged to SdeA 275-284 by phosphoribose. We applied low-energy HCD (high-energy collisional dissociation) fragmentation to specifically cleave the phosphoramidate bond, and confirmed that the generated fragment ion corresponded to SdeA 275-284 and phosphoribosylated Ub 34-48 (Fig. 2c ). This analysis revealed that H277 of SdeA is linked by phosphoribose to Ub through a phosphoramidate bond. We further validated the identity of the histidine-bridged intermediate by high-energy fragmentation generated ion series of the peptide backbones (Extended Data Fig. 5b ). Using rhodamine-labelled and haemagglutinin-labelled ubiquitin, we observed that both ubiquitin variants attached to SdeA 213-907 (H407N) in a heat-dependent manner (Extended Data Fig. 5c, d ). Upon heating, the levels of intermediate decreased with a concomitant increase of PR-Ub, indicating that PR-Ub is attached to a catalytic histidine of SdeA (Extended Data Fig. 5e ). Notably, residue E340 of SdeA forms a hydrogen bond with H277, potentially activating this histidine to be a strong nucleophile 13 ( Fig. 2a) . Both double mutants (H277A/H407N and E340A/H407N) failed to form the intermediate, supporting our notion that H277 is the intermediate-forming residue and that E340 has a critical role in the activation of H277 (Extended Data Fig. 5f ). Based on the observed stabilization of the intermediate in H407 mutants, we propose a general role for H407 in orienting and activating a water molecule or the substrate serine for a nucleophilic attack on H277-PR-Ub (Fig. 2d) . Accordingly, SdeA 213-907 (H407N) is defective in substrate ubiquitination and only partially active in producing PR-Ub (Extended Data Fig. 6a ). We propose a two-step phosphoryl transfer reaction scheme for the PDE-mediated PR-ubiquitination of substrates (Fig. 2d ). This model is also supported by the crystal structure of ADPR-Ub in complex with the PDE domain of SdeD 14 . In addition to revealing critical roles for the two histidine residues, the structure of PDE also showed that side chains of Y347 and R413 are inserted into the catalytic centre and could be potentially involved in either the phosphoryl transfer activity or the binding of ADPR-Ub to SdeA (Fig. 2a) . Mutating these residues into alanine inhibited PR-ubiquitination by SdeA (Extended Data Fig. 6b, c) .
To gain insights into substrate recognition by SdeA, we set out to identify ubiquitination sites within the recently described SdeA substrate RTN4B using a mass-spectrometry-based approach 3 . We found two ubiquitination sites in the cytoplasmic part of RTN4B, where each site contained two serine residues that are targeted by SdeA for ubiquitination (Extended Data Fig. 7a, b ). RTN4B peptides of about 13 residues containing the target serine residues served as substrates for SdeA (Fig. 3a) . Alignment of all peptide sequences containing known SdeA target serines using Seq2logo server 15 generated a sequence motif (Fig. 3b, Extended Data Fig. 7c ), in which the target serine is in the vicinity of hydrophobic residues and is flanked by proline residues.
Furthermore, we produced 47 degenerate peptides based on one of the RTN4B ubiquitination sites and performed ubiquitination assays with all of them (Supplementary Table 3 , Supplementary Information, Fig. 3c ). Individual peptide sequences and their fractional activity were given as inputs for NNalign server to generate a sequence motif 16 . The resulting sequence motif confirms the importance of hydrophobic residues surrounding the target serine sites for SdeA ubiquitination (Fig. 3d) . Notably, we have identified an AMP analogue, adenosine 5′-O-thiomonophosphate (AMPS), that acts as a low-affinity inhibitor of substrate ubiquitination by the SdeA PDE domain by affecting substrate positioning ( Supplementary Information, Extended Data Fig. 8 ). AMPS also inhibited the ubiquitination activity of SdeC, a paralogue of SdeA (Extended Data Fig. 8g ), indicating the potential implications of this lead compound in developing novel inhibitors against this class of Legionella toxins.
Further inspection of the SdeA PDE domain structure revealed the existence of a cleft on the surface that leads to the active site of the PDE containing the catalytic residue H277 (Fig. 4a) . We hypothesized that this cleft could bind and position polypeptides containing substrate serines. We identified several SdeA cleft mutants (Fig. 4b ) that are associated with a substantial decrease in substrate ubiquitination, while showing negligible effect on phosphoribosylation of ubiquitin (Fig. 4c, Extended Data Fig. 9a ). Among the mutants, M408A, L411A and M408A/L411A had the biggest effect on Rab33b ubiquitination in both SdeA 213-907 and SdeA FL . These mutations also affected ubiquitination of RTN4B, indicating that SdeA recognizes multiple structurally different substrates via this region (Fig. 4d) .
The identification of substrate-binding mutants of SdeA enabled us to investigate which of its two functions (phosphoribosylation of ubiquitin or substrate ubiquitination 3 ) is physiologically relevant. The L. pneumophila ΔsidEs mutant 2 was complemented with either wild-type SdeA FL or various substrate-binding mutants (Extended Data Fig. 9b ). Both the M408A and M408A/L411A mutants lacked the ability to complement the growth of the bacterial strain lacking the sidE effector family in the amoeba host Dictyostelium discoideum (Fig. 4e, Extended Data Fig. 9c ) and also failed to restore the ∆sidEs mutant in the recruitment of RTN4 to the Legionella-containing vacuole during infection in primary mouse macrophages ( 
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substrates for ubiquitination rather than the modification of ubiquitin is the central function of SdeA in acute bacterial pathogenicity.
The SdeA structure and the detailed biochemistry presented here give us a first-hand glimpse into the atomic details of the PR-ubiquitination catalysed by the SidE family of bacterial enzymes and enable us to pin down substrate ubiquitination as the pathogenic principle of SdeA. PR-ubiquitination by the PDE domain progresses through a transient intermediate in the form of SdeA H277-PR-Ub, which is subsequently attacked by the OH group of the target serine of the substrate for successful ubiquitin transfer. This suggests a double displacement mechanism for PDE catalysis in which the binding of PR-ubiquitination substrates at the PDE active site may first require release of AMP generated during the intermediate formation. This is consistent with the juxtaposed catalytic groove of PDE domain and the substrate binding cleft. Notably, the active sites of mART and PDE face opposite sides of the molecule (Fig. 1a, b) , hinting that there may not be a direct transfer of ADP-ribosylated ubiquitin between the catalytic centres of the mART and PDE domains. However, potential dimerization of SdeA, as observed with purified proteins in solution (Extended Data Fig. 10 ), may enable these two catalytic sites to face each other in trans. Sequence analysis of SdeA substrates revealed that the target serine residues could occur in disordered regions in line with the limiting size of the substrate-binding cleft in the SdeA PDE domain (Fig. 4b) . On the basis of the substrate recognition motif identified in this study, we propose that SdeA could be a broad-specificity ligase that targets disordered serine residues in multiple substrates. Therefore, the specificity of SdeA-mediated ubiquitination during Legionella infection could be conferred by its recruitment to the endoplasmic reticulum, where currently identified in vivo substrates of SdeA reside 2, 9 . The dissection of PR-ubiquitination catalysis by SdeA presented here may also aid the future discovery of related mammalian enzymes.
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MEthodS
Expression and purification. Expression and purification of SdeA and Rab33b have previously been described 2 . In brief, T7 express cells were transformed with wild-type SdeA (UniProt accession code: Q5ZTK4) or mutant constructs cloned in a modified pET21a vector with a C-terminal CPD (cysteine protease domain)-His tag. Rab33b was cloned into a pET21a vector with a C-terminal His tag. For selenomethionine-labelled SdeA 213-907 , the plasmid was transformed into B834 competent cells and was expressed using selenomethionine-containing minimal medium (Molecular Dimensions). T7 express transformed cells were grown in LB medium at 37 °C to an optical density (OD) of 0.6-0.8, induced with 0.5 mM IPTG (isopropyl β-d-1-thiogalactopyranoside), grown overnight at 18 °C and collected. The cell pellet was resuspended in a buffer containing 50 mM Tris-HCl pH 7.5, 300 mM NaCl, 10% (v/v) glycerol, 1 mM PMSF, DNAse and protease inhibitor cocktail tablets (Roche). The cells were lysed by sonication. Clarified supernatant (12,000 r.p.m., 4 °C, 40 min) was incubated for 1 h with pre-equilibriated Talon beads before being washed three times with 50 mM Tris-HCl pH 7.5, 300 mM NaCl, 10% (v/v) glycerol. For RTN4B purification, the clarified supernatant was spun again (40,000 r.p.m., 4 °C, 90 min) to collect membrane fractions. The membranes were homogenized and solubilized in the presence of 1% n-dodecyl β-d-maltoside (DDM). For the rest of the RTN4B purification, 0.05% (w/v) DDM was maintained in the buffer. For Rab33b purification, the protein was eluted using 200 mM imidazole after binding to Talon beads. The CPD-His tag of SdeA and RTN4B was cleaved off the protein while it was still bound to Talon beads using 100 µM phytic acid. For biochemical assays, the buffer was exchanged to a final buffer of 10 mM HEPES pH 7.5, 150 mM NaCl and 1 mM TCEP. For crystallization, SdeA 213-907 was loaded onto a Q-sepharose column after CPD tag cleavage. SdeA 213-907 eluted in flowthrough, while most of the impurities were bound to the column. The fraction containing the protein was then concentrated before injecting into a Superdex 75 16/60 size-exclusion chromatography column pre-equilibrated with 10 mM HEPES pH 7.5, 150 mM NaCl, 1 mM TCEP. The protein eluted in a single peak and fractions were pooled together and concentrated to 25 mg/ml before setting up crystallization screens. Limited proteolysis. One milligram of SdeA 193-998 was incubated with 50 µg GluC in 20 mM HEPES pH 7.5, 50 mM NaCl and 10 mM MgSO 4 for 1 h on ice. This was followed by size-exclusion chromatography of the reaction on a Superdex 75 16/60 column equilibrated with 10 mM HEPES pH 7.5, 150 mM NaCl. The fractions were pooled and protein matrix assisted laser desorption/ionization (MALDI) mass spectrometry was performed. The protein fragment of interest was then identified based on the exact mass using the Expasy server tool Findpept. Various constructs of SdeA were also similarly proteolysed by GluC and analysed by Coomassie stained SDS gel. Data collection, data processing and structure solution. Both SeMet and native diffraction data were collected at the PXIII beamline of the Swiss Light Source, Villigen. Native data were collected at wavelength 1.00003 Å. The data were processed using XDS 17 . SAD (single anomalous dispersion) data from SeMet crystals were collected at wavelength 0.97927 Å and processed using XDS, and the phases were calculated using Phenix autosol 18 . Using these initial phases, buccaneer was used to build most of the PDE domain and segments of mART and AHL that were well-ordered 19 . After manual correction of the output model of buccaneer, MR-SAD (molecular replacement-single-wavelength anomalous dispersion) was performed using PHENIX autosol to further improve the phases. Further building was done manually in Coot using SeMet positions as a guide 20 . Using the model obtained from experimental phases, molecular replacement was performed for the native data of SdeA extending to 2.8 Å. Further iterative cycles of manual building and refinement were performed using coot and refinement programs phenix refine and Buster (Global phasing) 18, 21 . Ramachandran statistics for the refined SdeA core structure are favoured: 93.6%, allowed: 6.4%, outliers: none. In vitro ubiquitination assays. SdeA ubiquitination experiments were done as described 3 . In brief, 2.5 µg purified untagged ubiquitin and 2 µg Rab33b were incubated with 1 µg SdeA (FL, 213-907 wild-type and variants and SdeA PDE domain) at 37 °C for 30 min in the presence or absence of 200 µM NAD + in a buffer containing 50 mM Tris-HCl pH 7.5, 50 mM NaCl in a final reaction volume of 30 µl. For reactions involving the SdeA PDE domain, purified ADP ribosylated ubiquitin (2.5 µg) was used instead of NAD + . ADP ribosylated ubiquitin was generated using the SdeA H277A mutant and purified using size-exclusion chromatography. The reaction mixture was subjected to SDS-PAGE followed by Coomassie staining. Alternatively, the reaction mixture was subjected to SDS-PAGE followed by western blotting using ubiquitin antibody and pan-ADP ribose antibody (Millipore) or to phosphostaining to identify PR-UB (Pro-Q diamond phosphostaining protocol, Thermo Fisher). For ubiquitination assays using FL GFP-tagged SdeA constructs, we transfected 2 µg GFP-tagged SdeA constructs into HEK293T cells cultured in 6-well plates. HEK293T cells were obtained from ATCC (ATCC CRL-3216) and authenticated using STR DNA profiling. All the cell lines used tested negative for mycoplasma. Cells were collected after 24 h and lysed in 150 µl lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 10% glycerol, protease inhibitors cocktail and 1 mM PMSF). Using 15 µl GFP-trap beads, we purified the GFP-tagged SdeA proteins from the clarified lysate. After extensive washing of the beads, an in vitro ubiquitination reaction was set up in 30 µl reaction buffer (50 mM Tris-HCl, 50 mM NaCl, pH 7.4) with 3 µg purified Rab33b, 2.5 µg ubiquitin and 0.2 mM NAD + . The reaction was performed at 37 °C in a thermomixer while shaking. After 30 min, the reaction was stopped by adding SDS loading buffer and the samples were analysed using Coomassie staining of SDS gel and western blotting. The reaction mixture was analysed similarly to the assays using bacterially purified SdeA 213-907 except for the use of complementary ubiquitin antibodies (CS-Ub and abcam-Ub) to monitor ubiquitin modification 3 .
Where indicated, ADPR-Ub was used as co-factor in reactions instead of Ub and NAD. Peptide ubiquitinations were carried out with 0.5 mM of each peptide as substrate with SdeA FL . All experiments were repeated at least twice. ε-NAD + hydrolysis. For measuring the ubiquitin ADP-ribosylation kinetics of SdeA 213-907 and its mutants, we used an ε-NAD hydrolysis assay 7 . Five micrograms of wild-type or mutant SdeA was incubated in a buffer containing 50 mM Tris pH 7.5, 50 mM NaCl with 100 µg ubiquitin in 100 µl reaction buffer. ε-NAD was added to final concentration of 1 mM to start the reaction. Fluorescence of ε-adenine (excitation wavelength: 300 nm, emission wavelength: 410 nm) was monitored using a plate reader at 25 °C at every 1-min interval. Constructs of the C-terminal region (909-1499 and 909-1233) were added in 1.5 molar excess of SdeA 213-907 to test their effect on activity. All experiments were repeated at least twice.
Histidine intermediate analysis.
This analysis was performed as described previously with slight modifications 12 . In brief, 4 µg wild-type or mutant SdeA 213-907 was incubated with 10 µg ubiquitin or labelled ubiquitin and 2 mM NAD + for 5 min at 37 °C. The reaction was stopped by transferring the contents onto ice and adding 5× SDS loading buffer (pH 8.8). Gel electrophoresis and transfer were conducted at 4 °C and analysed by Coomassie staining, fluorescence scanning or western blotting. All experiments were repeated at least twice. Small-angle X-ray scattering. SdeA 213-907 was purified in 10 mM HEPES pH 7.5, 150 mM NaCl, 1 mM TCEP by size-exclusion chromatography (Superdex 200 increase). Each fraction was collected and concentrated with centrifugal concentration devices (50-kDa cut-off, Supplementary Table 2, Supplementary Information). The scattering profile of flow-through buffer from the size-exclusion column was recorded as reference buffer scattering. SAXS data were collected at beamline P12, EMBL-DESY (Supplementary Table 2 , Supplementary Information). Primary data analysis was performed using PRIMUS from the ATSAS package 22 . Bead modelling was conducted with DAMMIF 23 and DAMMIN 24 from the ATSAS package. SAXS curves from atomic model were generated and fitted to experimental data using CRYSOL 25 and SUPCOMB 26 from ATSAS 2.8.3 package. Mass spectrometry. For analysis of the histidine intermediate, an in vitro ubiquitination reaction of SdeA 213-907 (H407N) was stopped after 5 min by denaturation on ice in 5.3 M urea pH 8.8 for 10 min. The sample was diluted to 2 M urea with 50 mM ABC pH 8.8 and was loaded onto a 30-kDa filter (Amicon Ultra, 0.5 ml, Merck). (Ub-)SdeA was trypsinized according to an adapted FASP-protocol as previously described 3 . In brief, the proteins were washed four times with 100 µl ABC and after adding Trypsin Gold (Promega) in an enzyme:protein ratio of 1:2, tryptic digestion was performed for 20 min at 22 °C. Tryptic peptides in 50 mM ammonium bicarbonate pH 8.8 were loaded onto a 15-cm self-packed C18 column and separated with a short gradient (12 min from 10-38% buffer B (80% acetonitrile, 0.1% formic acid)) on an easy nLC2 system and injected online into a Q Exactive HF mass-spectrometer. Targeted MS2 scans were used to specifically fragment the bridged intermediate with different collision energies. For partial and specific fragmentation of the phosphoramidate bond, a normalized collision energy (NCE) of 15 was applied, and for fragmentation of the peptide backbone NCE 30 was used. Spectra were annotated manually and StavroX 3.6 was used for additional identification of the peptide backbone fragments 27 . Identification of phosphoribose-bridged ubiquitination sites in RTN4B was done as described before by HCD and targeted ETD fragmentation after a modified FASP digest 3 . L. pneumophila strains and host infections. L. pneumophila strains used in this study were derivatives of the Philadelphia 1 strain Lp02 1 and were grown and maintained on CYE (charcoal-yeast extract) plates or in N-(2-acetamido)-2-aminoethane (ACES) buffered yeast extract (AYE) broth as previously described 28 .
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The sidE family in-frame deletion strain and complementation strains have been described previously 2 . sdeAM408A and sdeAM408A_L411A mutant genes were cloned into pZL507 3 for complementation. Raw264.7 cells were cultured in RPMI 1640 medium supplemented with 10% FBS. D. discoideum AX4 cells were cultured in HL-5 medium and maintained in MB medium for infection as described 2 . Infection experiments were performed in triplicate. Infection. L. pneumophila strains were grown to the post-exponential phase (OD 600 = 3.0-3.6) in AYE broth. Complementation strains were induced with 0.2 mM IPTG for 4 h at 37 °C before infection. Raw 264.7 cells were infected with L. pneumophila strains at an MOI of 10 for 2 h to detect the translocation of SdeA and its mutants. Raw cells were collected and lysed with 0.2% saponin on ice for 30 min. Cleared cell lysates were resolved by SDS-PAGE, followed by immunoblotting with antibodies specific for SdeA and tubulin. Total L. pneumophila proteins were resolved by SDS-PAGE to evaluate the expression of SdeA by immunoblotting with SdeA-specific antibodies, and isocitrate dehydrogenase (ICDH) was probed as a loading control with previously described antibodies 29 . For intracellular growth in D. discoideum, infection was performed at an MOI of 0.1 and the total bacterial counts were determined at 24-h intervals as described 30 . The enrichment of RTN4 by bacterial phagosomes was assessed by immunostaining in primary mouse macrophages infected with the relevant L. pneumophila strains for 2 h at an MOI of 1.0. Primary mouse macrophages were obtained from A/J mouse (female, 6 weeks, Jackson lab cat#000646). No randomization of mice and blinding was necessary as mice were used only to collect primary bone marrow macrophages for Legionella infection experiments. Immunostaining with anti-RTN4 (Lsbio cat#LS-B6516-50) (1:500) was performed as described 9 . Infection experiments were performed in triplicate. Antibodies and immunoblotting. For immunoblotting, samples resolved by SDS-PAGE were transferred onto 0.2-µm nitrocellulose membranes (Pall Life Sciences cat#66485). Membranes were blocked with 5% non-fat milk and incubated with the appropriate primary antibodies: anti-SdeA2, 1:10,000, anti-ICDH3, 1:10,000, anti-tubulin (DSHB, E7) 1:10,000. Membranes were then incubated with an appropriate IRDye infrared secondary antibody (dilution: 1:20,000) and scanned using an Odyssey infrared imaging system (Li-Cor's Biosciences). Ethical compliance. Animal protocols used in the study were approved by Purdue Animal Care and Use Committee. We complied with all the relevant ethical regulations. No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment.
Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this paper. Data availability. Structure coordinates are available from the Protein Data Bank under accession code 6G0C. Small-angle X-ray scattering data and models are available from SASBDB (https://www.sasbdb.org/) under accession number SASDD65. Full gel source data can be found in Supplementary Fig. 1 . The data that support the findings of this study are available from the corresponding author upon request. The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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available from SASBDB (SASBDB ID:SASDD65). Full gel source data can be found in SI Figure 1 . The data that support the findings of this study are available from the corresponding author upon request.
Field-specific reporting All studies must disclose on these points even when the disclosure is negative.
Sample size
No sample size calculation was done. Sample size was estimated to be sufficient based on the consistency and magnitude of measured differences between groups.
Data exclusions No data were excluded from analysis.
Replication
All attempts replicated similar results.
Randomization No randomization of mice was necessary as mice were only used to collect primary bone marrow macrophages for Legionella infection experiments.
Blinding
Blinding was not necessary for Legionella infection experiments as every colony was counted to estimate the colony forming units regardless of the sample groups.
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